Walgreens Boots Alliance Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Walgreens Boots Alliance şirketinin kazançları yıllık ortalama -50.6% oranında azalırken, Consumer Retailing sektörünün kazançları yıllık 13.2% oranında artan oldu. Gelirler yıllık ortalama 3.3% oranında artan oldu.

Anahtar bilgiler

-50.6%

Kazanç büyüme oranı

-50.3%

EPS büyüme oranı

Consumer Retailing Sektör Büyümesi	10.9%
Gelir büyüme oranı	3.3%
Özkaynak getirisi	-126.8%
Net Marj	-5.8%
Son Kazanç Güncellemesi	31 Aug 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Gelir ve Gider Dağılımı

Walgreens Boots Alliance nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

NasdaqGS:WBA Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
31 Aug 24	147,658	-8,636	25,685
31 May 24	145,533	-5,811	25,788
29 Feb 24	144,597	-6,037	26,123
30 Nov 23	142,406	574	25,805
31 Aug 23	139,081	-3,080	25,785
31 May 23	136,108	-3,315	26,031
28 Feb 23	133,291	-3,144	25,591
30 Nov 22	132,184	-2,964	25,531
31 Aug 22	132,703	4,337	25,246
31 May 22	134,516	5,111	26,292
28 Feb 22	135,948	5,926	25,909
30 Nov 21	134,972	5,965	25,232
31 Aug 21	132,509	1,994	24,165
31 May 21	128,617	1,972	23,305
28 Feb 21	124,952	-926	23,194
30 Nov 20	123,509	-981	23,052
31 Aug 20	121,982	179	23,144
31 May 20	125,566	519	23,676
29 Feb 20	129,792	3,339	24,269
30 Nov 19	132,984	3,628	24,521
31 Aug 19	120,074	3,816	23,183
31 May 19	136,354	4,817	25,135
28 Feb 19	136,097	5,133	25,112
30 Nov 18	134,590	5,326	25,065
31 Aug 18	131,537	5,024	24,638
31 May 18	128,244	4,314	23,745
28 Feb 18	124,028	4,134	23,520
30 Nov 17	120,453	3,845	23,067
31 Aug 17	118,214	4,078	23,618
31 May 17	116,701	4,306	23,115
28 Feb 17	116,081	4,247	23,046
30 Nov 16	116,819	4,117	23,302
31 Aug 16	117,351	4,173	23,425
31 May 16	117,237	3,169	23,409
29 Feb 16	116,534	3,368	23,433
30 Nov 15	112,923	4,480	22,996
31 Aug 15	103,444	4,220	21,669
31 May 15	93,979	3,973	20,224
28 Feb 15	84,585	3,385	18,611
30 Nov 14	77,617	2,059	17,661
31 Aug 14	76,392	1,932	17,691
31 May 14	75,276	2,810	17,684
28 Feb 14	74,188	2,720	17,579
30 Nov 13	73,230	2,760	17,473

Kaliteli Kazançlar: WBA şu anda kârlı değil.

Büyüyen Kar Marjı: WBA şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: WBA kârlı değildir ve zararlar son 5 yılda yılda 50.6% oranında artmıştır.

Büyüme Hızlandırma: WBA 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: WBA kârlı olmadığından, geçmiş yıl kazanç büyümesinin Consumer Retailing sektörüyle ( 10.8% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: WBA hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -126.83% ) sahiptir.

Walgreens Boots Alliance Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Walgreens Q4: 2 Signs Of A Dividend Trap

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens: A Turnaround Stock To Avoid

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Price target decreased by 7.5% to US$11.33

Price target decreased by 7.8% to US$11.46

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Is Walgreens Ready To Rebound?

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Walgreens: A Painful Turnaround Lesson

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Walgreens: Here's What Comes Next

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc